Discontinued — last reported Q3 '23

Business Segments · Revenue

Delivery Systems — Revenue

West Pharmaceutical Services Delivery Systems — Revenue increased by 6.7% to $144.90M in Q3 2023 compared to the prior quarter. Year-over-year, this metric grew by 20.8%, from $120.00M to $144.90M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ3 2023
Rolls up toTotal Revenue

How to read this metric

Increasing revenue indicates strong market adoption and successful commercialization of proprietary delivery technologies.

Detailed definition

This metric represents the total net sales generated by the Delivery Systems business segment. It reflects the market de...

Peer comparison

Comparable to segment-specific net sales reported by other medical device or pharmaceutical packaging manufacturers.

Metric ID: wst_segment_delivery_systems_revenues

Historical Data

6 periods
 Q2 '21Q3 '21Q2 '22Q3 '22Q2 '23Q3 '23
Value$136.40M$129.70M$117.80M$120.00M$135.80M$144.90M
QoQ Change-4.9%-9.2%+1.9%+13.2%+6.7%
YoY Change-13.6%-7.5%+15.3%+20.8%
Range$117.80M$144.90M
CAGR+5.0%
Avg YoY Growth+3.7%
Median YoY Growth+3.9%
Current Streak3 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's delivery systems — revenue?
West Pharmaceutical Services (WST) reported delivery systems — revenue of $144.90M in Q3 2023.
How has West Pharmaceutical Services's delivery systems — revenue changed year-over-year?
West Pharmaceutical Services's delivery systems — revenue increased by 20.8% year-over-year, from $120.00M to $144.90M.
What does delivery systems — revenue mean?
The total revenue earned specifically from the Delivery Systems business unit.